Science and innovation are the lifeblood of our company. But we’re
doing more than developing medicines that perform well in the
lab—we’re elevating the current standard of care to bring greater
benefits to our patients.
Published 1,150+ papers
AbbVie scientists in the medical
research community published more than 1,150 papers in 2019 - allowing others to build on scientific knowledge we’ve developed.
Bringing Better Solutions to Patients
By investing in groundbreaking technologies and platforms, our goal is to drive innovation within our pipeline and deliver better solutions to patients.
invested to advance science
*Excluding specified items
of medicines in our pipeline are considered first-in-kind
scientists working globally to make a difference